Visceral Leishmaniasis Masquerading as Drug-Induced Pancytopenia in Lung Cancer Patients.
Humans
Pancytopenia
/ chemically induced
Leishmaniasis, Visceral
/ drug therapy
Male
Middle Aged
Lung Neoplasms
/ drug therapy
Carcinoma, Non-Small-Cell Lung
/ drug therapy
Diagnosis, Differential
Pemetrexed
/ therapeutic use
Antineoplastic Agents
/ adverse effects
Antiprotozoal Agents
/ therapeutic use
Amphotericin B
/ therapeutic use
chemotherapy
lung cancer
pancytopenia
visceral leishmaniasis
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
17 Apr 2024
17 Apr 2024
Historique:
received:
01
04
2024
revised:
10
04
2024
accepted:
15
04
2024
medline:
26
4
2024
pubmed:
26
4
2024
entrez:
26
4
2024
Statut:
epublish
Résumé
Maintenance chemotherapy is a standard treatment in patients with non-progressive advance staged IV non-squamous non-small cell lung cancer after induction therapy. Here, we report the case of a 53-year-old man undergoing a maintenance monotherapy with pemetrexed who presented prolonged pancytopenia despite filgrastim injections. A bone marrow aspiration revealed a macrophage activation syndrome with
Identifiants
pubmed: 38668071
pii: curroncol31040168
doi: 10.3390/curroncol31040168
doi:
Substances chimiques
liposomal amphotericin B
0
Pemetrexed
04Q9AIZ7NO
Antineoplastic Agents
0
Antiprotozoal Agents
0
Amphotericin B
7XU7A7DROE
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM